FFEA.F 3.73 (+1.63%)
ES0134950F36Drug ManufacturersDrug Manufacturers - Specialty & Generic

Faes Farma (FFEA.F) Stock Highlights

3.73 | +1.63%
2024-06-03 01:54:23
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Statistics

Range Today
3.73 3.73
Volume Today 0
Range 1 Year
2.85 3.68
Volume 1 Year 13.62K
Range 3 Year
2.85 4.22
Volume 3 Year 62.84K
Range 10 Year
1.673 5.33
Volume 10 Year 304.71K

Highlights

Market Capitalization 1.3B (small)
Floating Shares 287.8M
Current Price 3.73
Price To Earnings 12.86
Price To Revenue 2.37
Price To Book 1.75
Earnings Per Share 0.29
Dividend Yield 2.03%
Dividend Per Share 0.07
Payout Ratio 0%

Performance

Latest +1.63%
1 Month +11.34%
3 Months +22.3%
6 Months +20.32%
1 Year +13.37%
3 Years +11.41%
5 Years -4.48%
10 Years +72.45%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.